Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

SHA:603439 Revenue

Guizhou Sanli Pharmaceutical Co.,Ltd had revenue of 413.20M CNY in the quarter ending September 30, 2026, with 22.73% growth. This brings the company's total for the last twelve months to 1.64B, down -5.70% year-over-year. In the year 2025, Guizhou Sanli Pharmaceutical Co.,Ltd had annual revenue of 1.70B, down -20.59%. That makes Guizhou Sanli Pharmaceutical Co.,Ltd the 16,001st largest company in the world by revenue and 2,897th in China.

• Revenue (ttm): 1.64B
• Revenue Growth: -5.70%
• P/S Ratio: 2.56
• Revenue / Employee: 867.44K
• Employees: 1,887
• Market Cap: 4.19B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.70B	-441.54M	-20.59%
Dec 31, 2024	2.14B	509.41M	31.16%
Dec 31, 2023	1.63B	433.66M	36.10%
Dec 31, 2022	1.20B	262.35M	27.94%
Dec 31, 2021	938.97M	308.74M	48.99%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error